EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Neuroepidemiological Transition in Brazil: Nationwide Trends in Cerebrovascular, Dementia, Alzheimer’s, and Parkinson’s Mortality, 2000–2024

Djiovana Zanini, Marina Gervini Wendt, Bruna Costa Silveira, Érica Paiva Espinosa, Antônio Terra Brinquês, Renan Pablo Bittencourt Lobato, Thiago Falson Santana, Eduarda Neutzling Drawanz, Aline Longoni, Adriano Martimbianco de Assis

International Journal of Environmental Research and Public Health · 2026-11-07 · 23 (11) · 1400

DOI: 10.3390/ijerph23111400 ↗
AbstractBibliografische Angaben

Abstract

Neurological mortality may change through population ageing, shifts in age-specific mortality, and changes in diagnostic ascertainment and death certification. We examined recorded underlying-cause mortality from cerebrovascular disease, dementia, Alzheimer’s disease, and Parkinson’s disease in Brazil from 2000 to 2024. We analyzed 30,593,956 death records from the Brazilian Mortality Information System. Age-standardized mortality rates (ASMRs) were calculated using the WHO World Standard Population and modeled with inverse-variance-weighted piecewise log-linear regression. We additionally derived a study-specific descriptive Neuroepidemiological Transition Index (NTI), defined as dementia/cerebrovascular ASMR, and applied Shapley decomposition. Cerebrovascular mortality declined from 63.69 to 36.88 per 100,000 (average annual percentage change [AAPC] −2.17%; 95% CI, −2.29 to −2.05), whereas dementia increased from 1.75 to 11.39 (AAPC +8.04%), Alzheimer’s disease from 1.24 to 9.74 (+9.18%), and Parkinson’s disease from 0.81 to 2.11 (+4.05%). The NTI increased from 0.028 to 0.309 (AAPC +10.59%; 95% CI, 10.27–10.91). In the Shapley decomposition, 63.8% of the increase in dementia deaths was assigned to changes in age-specific recorded mortality rates, compared with 27.3% for population ageing and 9.0% for population growth. Brazil showed a marked shift in the composition of recorded neurological mortality, with implications for vascular prevention, dementia risk reduction, healthy ageing, and long-term care.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →